Calcium D-Pantothenate Encyclopedia — Scientific Background

What Is Calcium D-Pantothenate?

Calcium D-pantothenate (CAS 137-08-6), also known as D-calcium pantothenate or vitamin B5 calcium, is the calcium salt of the dextrorotatory isomer of pantothenic acid (vitamin B5). It is chemically characterized by the molecular formula C₁₈H₃₂CaN₂O₁₀ and a molecular weight of 476.53 g/mol. The compound is the calcium salt of (R)-pantothenic acid, chemically designated as β-alanine, N-(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)-, calcium salt (2:1), (R)-.

Physiological Functions of Calcium D-Pantothenate

Vitamin B5 is critical for numerous physiological functions:

• Coenzyme A Synthesis — Pantothenic acid is the fundamental precursor for the biosynthesis of coenzyme A (CoA). CoA is indispensable for the tricarboxylic acid (TCA) cycle, fatty acid synthesis, and the metabolism of carbohydrates, proteins, and fats.

• Cellular Energy Metabolism — CoA is required for the conversion of carbohydrates, fats, and proteins into ATP. Vitamin B5 supports mitochondrial energy production and contributes to the reduction of tiredness and fatigue.

• Lipid Metabolism — CoA is essential for fatty acid synthesis and oxidation, cholesterol synthesis, and steroid hormone production.

• Neurotransmitter Synthesis — CoA is required for the synthesis of acetylcholine, a neurotransmitter essential for cognitive function and neuromuscular signaling.

• Skin Barrier and Moisturization — Supports skin barrier maintenance, hydration, and natural moisture retention through enhanced CoA synthesis in epithelial cells.

• Adrenal Function — Contributes to healthy adrenal function and the body‘s natural response to physical stress.

Mechanisms of Action

Coenzyme A Synthesis and Cellular Energy Metabolism

Calcium D-pantothenate is converted to pantothenic acid, which is then phosphorylated and incorporated into CoA through a series of enzymatic reactions. CoA is a central metabolic cofactor required for the TCA cycle, fatty acid synthesis, cholesterol synthesis, and the acetylation of proteins and neurotransmitters. Its biological significance is primarily derived from its role as the fundamental precursor for the biosynthesis of coenzyme A (CoA) and acyl carrier proteins.

SMVT Bypass and liposomal Absorption Pathways

Conventional vitamin B5 absorption is mediated by the sodium-dependent multivitamin transporter (SMVT), which is saturable. Liposomal encapsulation offers a biomimetic “Trojan horse” delivery mechanism that protects vitamin B5 from the acidic gastric environment. By utilizing a phospholipid bilayer, this technology enables non-saturable absorption pathways such as passive diffusion, endocytosis, and lymphatic uptake, effectively bypassing the competitive limitations of SMVT and the hepatic first-pass effect. Liposomal formulations of calcium D-pantothenate have been shown to increase bioavailability to 94.7% in comparative studies.

The Bioavailability Challenge

Despite its essential physiological functions, conventional oral vitamin B5 supplementation faces significant pharmacokinetic challenges. The primary absorption mechanism for pantothenic acid and its derivatives is the sodium-dependent multivitamin transporter (SMVT), which is saturable and exhibits dose-dependent absorption kinetics. At higher doses, SMVT becomes saturated, and absorption efficiency declines, limiting systemic bioavailability.

These limitations have driven the development of advanced delivery systems, including liposomal encapsulation. Liposomal formulations represent a promising technological advancement, offering a means to bypass saturable transporters and protect the nutrient from environmental degradation, thereby enhancing systemic bioavailability and therapeutic potential.

Liposomal Calcium D-Pantothenate

Liposomal encapsulation of calcium D-pantothenate provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the calcium D-pantothenate molecule, forming a protective shell that enhances stability, bioavailability, and cellular uptake. This delivery system:

• Achieves 94.7% bioavailability compared to conventional forms

• Bypasses SMVT saturation through non-saturable passive diffusion, endocytosis, and lymphatic uptake

• Protects calcium D-pantothenate from gastric degradation

• Enhances stability at moderately acidic pH and elevated temperatures

• Provides sustained release for prolonged CoA synthesis and cellular energy metabolism

Clinical Evidence

Wound Healing — Randomized Controlled Trial

A 12-week study (n=120) demonstrated that liposomal calcium D-pantothenate (500 mg/day) reduced wound healing times by 37% compared to placebo (p=0.002) through enhanced fibroblast proliferation. This finding supports the role of vitamin B5 in supporting tissue regeneration and epithelial repair.

Metabolic Management and Energy Metabolism

Vitamin B5 supports metabolic management through its role in lipid metabolism and steroid hormone synthesis. As a precursor to CoA, vitamin B5 is essential for the TCA cycle and fatty acid oxidation, supporting cellular energy production and contributing to the reduction of tiredness and fatigue.

Neuroprotection and Neurotransmitter Synthesis

Vitamin B5 enhances the synthesis of neurotransmitters like acetylcholine to support neurological health. CoA is required for the acetylation of choline to form acetylcholine, a neurotransmitter essential for cognitive function and neuromuscular signaling.

Safety and Regulatory

Calcium D-pantothenate has a well-established safety profile. It is a water-soluble vitamin, and excess amounts are excreted in the urine. No tolerable upper intake level (UL) has been established for pantothenic acid due to its low toxicity.

Regulatory Status:

• United States — Calcium pantothenate is Generally Recognized As Safe (GRAS) by the FDA under 21 CFR 184.1212 for use as a nutrient supplement, with no limitation other than current good manufacturing practice. It is listed in the FDA Substances Added to Food database with CAS Registry No. 137-08-6.

• European Union — Calcium D-pantothenate is authorized as a vitamin and mineral substance which may be used in the manufacture of food supplements.

• Japan — Calcium pantothenate is monographed in the Japanese Pharmacopoeia (JP19) with an assay specification of 98.0%–102.0%.

• Global Standards — Calcium D-pantothenate is monographed in the USP, European Pharmacopoeia, and Food Chemicals Codex (FCC) with an assay specification of 98.0%–102.0% on the dried basis.

Precautions: Calcium D-pantothenate is generally well tolerated. Individuals with known hypersensitivity to pantothenic acid or its salts should avoid supplementation. Pregnant or lactating women and children should consult a healthcare professional before use.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

89$/KG